Il Makiage Owner Oddity Tech Shares Plummet Despite ‘Record’ 2025 Performance

Why It Matters

The sharp share decline highlights how short‑term guidance and cost‑inflation risks can outweigh solid financial performance, affecting investor confidence in consumer‑tech firms.

Key Takeaways

• Revenue up 25% to $810 million in 2025.
• Q4 revenue grew 24% to $153 million, gross profit +20%.
• Shares fell over 50% after weak 2026 outlook.
• Algorithmic ad error raised user acquisition costs dramatically.
• No full‑year guidance; strategy unchanged, focus on long‑term growth.

Pulse Analysis

Oddity Tech’s 2025 financials illustrate a rare juxtaposition of robust top‑line growth and severe market backlash. The company’s revenue surge, powered by its flagship cosmetics brands and the Q4 debut of MethodIQ, pushed annual sales to $810 million and delivered an adjusted EBITDA of $163 million. Such figures would typically buoy investor sentiment, yet the firm’s decision to withhold full‑year guidance and project a 30% YoY revenue dip for Q1 2026 triggered a more than 50% plunge in its share price, underscoring the premium investors place on forward‑looking clarity.

The root of the volatility lies in an algorithmic disruption with Oddity’s largest advertising partner, which forced the brand into low‑quality auction spaces and inflated new‑user acquisition costs. This type of ad‑tech misstep is increasingly common as platforms refine machine‑learning models, and it can quickly erode profit margins for digitally native consumer brands. Oddity’s leadership claims to have identified the issue and is implementing corrective actions, but the episode serves as a cautionary tale about the fragility of growth engines that rely heavily on paid acquisition channels.

Looking ahead, Oddity maintains its strategic focus on brand expansion and repeat‑purchase metrics, signaling confidence in its underlying business fundamentals. Analysts will watch Q2 and Q3 performance closely to gauge whether acquisition costs normalize and if the company can sustain its growth trajectory without further guidance gaps. For investors, the key question is whether the short‑term earnings dip is a temporary blip or a harbinger of deeper operational challenges in a competitive beauty‑tech landscape.